GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.98 $7.70 Thursday, 18th Apr 2024 FATE stock ended at $5.04. This is 4.36% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 7.33% from a day low at $4.98 to a day high of $5.35.
90 days $4.10 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2023-09-13 $2.55 $2.57 $2.38 $2.39 2 632 462
2023-09-12 $2.46 $2.57 $2.44 $2.54 2 960 267
2023-09-11 $2.48 $2.53 $2.40 $2.44 2 954 468
2023-09-08 $2.49 $2.49 $2.34 $2.48 2 051 745
2023-09-07 $2.55 $2.56 $2.41 $2.47 2 415 508
2023-09-06 $2.74 $2.78 $2.57 $2.60 1 742 482
2023-09-05 $2.82 $2.99 $2.68 $2.71 2 988 030
2023-09-01 $2.52 $2.82 $2.52 $2.81 2 919 415
2023-08-31 $2.64 $2.66 $2.50 $2.51 1 499 829
2023-08-30 $2.69 $2.70 $2.61 $2.64 1 352 818
2023-08-29 $2.66 $2.66 $2.66 $2.66 0
2023-08-28 $2.65 $2.82 $2.62 $2.66 1 985 352
2023-08-25 $2.56 $2.67 $2.50 $2.63 1 721 628
2023-08-24 $2.71 $2.74 $2.56 $2.56 1 806 134
2023-08-23 $2.66 $2.83 $2.66 $2.71 1 737 653
2023-08-22 $2.75 $2.77 $2.60 $2.66 1 776 029
2023-08-21 $2.77 $2.78 $2.66 $2.73 1 454 525
2023-08-18 $2.75 $2.88 $2.73 $2.78 1 635 967
2023-08-17 $2.78 $2.84 $2.71 $2.78 1 755 546
2023-08-16 $2.90 $2.96 $2.78 $2.79 2 062 390
2023-08-15 $3.00 $3.05 $2.89 $2.93 1 820 737
2023-08-14 $3.08 $3.06 $2.93 $3.02 3 651 048
2023-08-11 $3.23 $3.30 $3.08 $3.09 2 828 503
2023-08-10 $3.37 $3.45 $3.21 $3.26 1 812 037
2023-08-09 $3.50 $3.76 $3.34 $3.40 2 800 443
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT